Pediatric Brain Cancer (CPTAC/CHOP, Cell 2020)
Integrated proteogenomic characterization across major histological types of pediatric brain cancer . We report a comprehensive proteogenomics analysis, including whole-genome sequencing, RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 histological types of childhood brain cancer: low-grade glioma (n = 93), ependymoma (32), high-grade glioma (25), medulloblastoma (22), ganglio-glioma (18), craniopharyngioma (16), and atypical teratoid rhabdoid tumor (12). Proteomics data identify common biological themes that span histological boundaries, suggesting that treatments used for one histological type may be applied effectively to other tumors sharing similar proteomics features. Immune landscape characterization reveals diverse tumor microenvironments across and within diagnoses. Proteomics data further reveal functional effects of somatic mutations and copy number variations (CNVs) not evident in transcriptomics data.
Can it answer your research question?
3 of 6 supportedOverall survival
SupportedVital status and time are populated; median follow-up 2.9 years; 192 cases with follow-up; endpoints: overall survival, disease-free interval.API
Progression or recurrence
SupportedA time to event is derivable: disease-free interval;
progression_or_recurrenceis informative for 100% of cases.APITreatment response
Not supportedNo treatment response is recorded in the harmonized records.API
Which drug was given
Not measuredThis field was not among those probed for this repository.
Stage-adjusted modelling
Not measuredThis field was not among those probed for this repository.
Analysis by race or ethnicity
SupportedRACE is informative for 100% of cases.API
At a glance
Every percentage is the repository’s own record of what is filled inSubjectCALC
As filed by the repository
Who is in the cohortAPI
- Sex116 Male · 83 Female
- Race146 White · 27 Other/Unavailable/Not Reported · 18 Black or African American · 8 3 other
- Ethnicity184 Not Hispanic or Latino · 13 Hispanic or Latino · 2 Unavailable/Not Reported
- Vital status159 LIVING · 40 DECEASED
What was measured, and on how many
- Mutation calls (panel, exome or genome)218 of 218 samples · 100%
- Copy number alterations190 of 218 samples · 87%
- RNA sequencing expression188 of 218 samples · 86%
- Reverse phase protein array218 of 218 samples · 100%
How complete all 8 clinical fields are - 8 informative for at least 80% of cases
Access
Processed data download from the cBioPortal study page or its public REST API; no account required. Primary raw data remain wherever the original investigators deposited them.
- Open components
- harmonized mutation, copy-number, expression and clinical files
- License
- Per-study terms; cBioPortal asks that the original study be cited
- Citation requirement
- Cite the original publication, and cite cBioPortal if the portal's harmonized files were used.
What it is good for
Written and checked by a reviewer, not generated from metadata.
No reviewed research questions yet. The measurements and field completeness above are machine-extracted and still useful for judging fit.
What it cannot tell you
Written by a reviewer against the source, not inferred from what is missing.
No reviewed limitations yet. Check the field completeness chart above before committing to an analysis. Low coverage on an endpoint you need is the most common blocker.
Who has used it
Articles that analyzed these data, counted separately from articles that only cited the paper. Only the first counts as reuse.
- Not assessed: this dataset has no accession specific enough for citation-based reuse tracing, so a shortfall cannot be measured.
Original publication
Articles that analyzed the data
Not searchable. See the note above.
Community examples
Share your exampleAnalyses someone ran on these data end to end, each with a receipt recording when it ran, against which packages and for how long.
Nobody has shared an analysis of this dataset yet. The examples on other datasets cover the common patterns and can be adapted - and if you adapt one, it belongs here.
Start here
Starter code generated from this record’s own identifiers, then the access steps.
Get the data in code
cBioPortal: clinical data and the full study bundlepython
import requests, pandas as pd
STUDY = "brain_cptac_2020"
base = "https://www.cbioportal.org/api"
clin = requests.get(f"{base}/studies/{STUDY}/clinical-data",
params={"clinicalDataType": "PATIENT", "projection": "SUMMARY"}, timeout=60).json()
patients = pd.DataFrame(clin).pivot_table(index="patientId", columns="clinicalAttributeId",
values="value", aggfunc="first")
print(patients.shape)
profiles = requests.get(f"{base}/studies/{STUDY}/molecular-profiles", timeout=60).json()
print([p["molecularProfileId"] for p in profiles])
# Whole study as flat files: https://cbioportal-datahub.s3.amazonaws.com/brain_cptac_2020.tar.gzThis page as data: limitations firstbash
curl -s https://cd2s.vercel.app/data/datasets/cbio-brain-cptac-2020.json | python3 -c '
import json, sys
r = json.load(sys.stdin)
for l in r["limitations"]:
print(l["severity"].upper(), "-", l["statement"][:120])
print("survival endpoint:", r["longitudinal"]["has_survival_endpoint"], "| treatment response:", r["longitudinal"]["has_treatment_response"])'Access steps
- Open the study in cBioPortalFor people
Harmonized molecular and clinical files are open. Cite the original publication, and cite cBioPortal if the portal's harmonized files were used.
https://www.cbioportal.org/study/summary?id=brain_cptac_2020 - Download the whole study as a zipFor people
The datasets page carries the staging files used by the portal.
https://www.cbioportal.org/datasets - Or pull the staging files with git-lfsFor people
Study folders are named by study id under public/.
https://github.com/cBioPortal/datahubgit clone https://github.com/cBioPortal/datahub.git && cd datahub git -c lfs.fetchexclude="" lfs pull -I public/brain_cptac_2020 - Read the study straight from the REST APIFor agents
No key is required; pace requests when sweeping many studies.
https://docs.cbioportal.org/web-api-and-clients/curl -s 'https://www.cbioportal.org/api/studies/brain_cptac_2020/clinical-data?clinicalDataType=PATIENT&projection=SUMMARY'
Provenance
All of it, and more, is in this record’s JSON.
Identifiers
- cBioPortal studybrain_cptac_2020API
Versions and verification
- Metadata retrieved
- 18 Sept 2026
- Review status
- Machine-extracted
- Data generation funding
- Funded data generation
Funding
Funded data generation
- U24CA210993Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision MedicineERIC E SCHADT, Pei WangAPI
- U24CA210985The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic TargetsDANIEL Wanyui CHAN, ZHEN ZHANGAPI
- U24CA210979Integrated high throughput proteogenomic data analysis center for CPTACChet Birger, GAD A GETZAPI
- U24CA210972Proteogenomic Data Analysis for Cancer Systems Biology and Clinical TranslationLi Ding, David FenyoAPI
- U24CA210967University of Michigan Proteogenomics Data Analysis CenterARUL M CHINNAIYAN, Saravana M DhanasekaranAPI
- U24CA210955PNNL Proteome Characterization CenterTao Liu, RICHARD D SMITHAPI
- U24CA210954iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTACBing ZhangAPI
- U01CA214114Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefitMichael Birrer, AMANDA G PAULOVICHAPI
- R50CA211499A proteomics research specialist in developing targeted mass spectrometry methods for quantifying proteins important in cancerJeff WhiteakerAPI
- P30CA008748Antitumor AssessmentElisa de Stanchina, FRANCESCA M GANYAPI